44 2033180199

Ligation of GSV in Sclerotherapy with Foam: Technical Notes: Personal Experience Paolo Valle

Domenico Spoletini, Domenico Monetti and Giampaolo Valle

Methodology & Theoretical Orientation:

From 1 January 2016 to today, in 79 patients (CEAP C2-C3), 85 sclerofoam treatments of GSV were performed for varicose veins of the lower limbs with: saphenofemoral reflux >3 sec, saphenous diameter >8 mm and at least 2 varicose thigh/leg collateral. To obtain the GSV, local surgical anesthesia was performed with a surgical access localized to the thigh, always above the end of the Hunter perforator and of the varicose collateral. The GSV is bound and sectioned and finally cannulated with an Arteriofix 8 mm catheter, through which, after washing with physiological solution, the sclerofoam with TDS 3% (ratio 1:4) for a maximum of 4 cc of foam according to Tessari’s technique. The remaining saphenous veins are removed with the Muller technique. Controls with ecocolordoppler are expected at 1, 3, 6 months and 1 year.

Findings: 

in 4 patients (4.7%), however very thin, was found, in the first month, a superficial phlebitis of the thigh, between the surgical incision and the inguinal fold. Recanalization occurred after 1 year in only 8 patients (9.4%). In any case the diameter of saphenous veins was reduced by more than 50%, the saphenous walls were thickened, there was no reflux at the saphenofemoral junction and clinically the patients reported no disturbances. In all other patients, GSV presented with obliterated and reduced caliber. Conclusion & Significance: From these first results we can state that this technique that includes the ligation of the GSV makes the foam more stable than that which occurs with the direct injection of the GSV. Furthermore, a smaller amount of foam is sufficient, with no local and general phenomena and complications

Haftungsausschluss: Dieser Abstract wurde mit Hilfe von Künstlicher Intelligenz übersetzt und wurde noch nicht überprüft oder verifiziert.
 
Peer-Review-Publikation für Verbände, Gesellschaften und Universitäten pulsus-health-tech
Top